Radiogenomics-based prediction of KRAS and EGFR gene mutation in non-small cell lung cancer patients
{{output}}
Objectives: Non-small cell lung cancer (NSCLC) is associated with poor prognosis, with 30% of patients diagnosed at an advanced stage. Mutations in the EGFR and KRAS genes are important prognostic factors for NSCLC, and targeted ... ...
